The effect of statins on aggression appears to differ based on sex and age, as a study published in PLOS ONE found that aggression increased in postmenopausal women taking statins but actually decreased in men.
The Food and Drug Administration (FDA) has approved Orkambi (lumacaftor/ivacaftor; Vertex), the first and only drug indicated for the treatment of cystic fibrosis (CF) in patients aged ≥12 who are homozygous for the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Region accounted for 7 to 8 percent of variation in thrombolysis treatment
Improvement in number of hours of direct exposure to sunlight without pain, quality of life
Beneficial effect for once-daily subcutaneous injection, together with lifestyle counseling
Consuming excess fluids can lead to dangerous drop in sodium levels
Reduction in inflammatory biomarkers among women with BMI 25 kg/m, low serum 25(OH)D
About half of cardiovascular deaths could be prevented with elimination of five major risk factors
Secondary school represents cost-effective intervention for HIV prevention in Botswana
Far too few Americans are surviving cardiac arrest, and a new report issued by the Institute of Medicine (IOM) offers strategies to boost survival rates.
- Paleo Diet: Should It Stay in the Stone Age?
- Risks and Recommendations: The Use of NSAIDs in Patients With Cardiovascular Disease
- Neurological Complications Caused by "Skinny Jeans"
- Popular Restaurant Meals That Pack a Caloric Punch
- What's the Secret to Longevity? Lessons from "Blue Zones" Worldwide